A genetic and pathologic study of a DENV2 clinical isolate capable of inducing encephalitis and hematological disturbances in immunocompetent mice.

Dengue virus (DENV) is the causative agent of dengue fever (DF), a mosquito-borne illness endemic to tropical and subtropical regions. There is currently no effective drug or vaccine formulation for the prevention of DF and its more severe forms, i.e., dengue hemorrhagic fever (DHF) and dengue shock...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jaime Henrique Amorim, Raíza Sales Pereira Bizerra, Rúbens Prince dos Santos Alves, Maria Elisabete Sbrogio-Almeida, José Eduardo Levi, Margareth Lara Capurro, Luís Carlos de Souza Ferreira
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/b882e572504c4675a87d61f09e5fbdc9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b882e572504c4675a87d61f09e5fbdc9
record_format dspace
spelling oai:doaj.org-article:b882e572504c4675a87d61f09e5fbdc92021-11-18T07:05:39ZA genetic and pathologic study of a DENV2 clinical isolate capable of inducing encephalitis and hematological disturbances in immunocompetent mice.1932-620310.1371/journal.pone.0044984https://doaj.org/article/b882e572504c4675a87d61f09e5fbdc92012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23028722/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Dengue virus (DENV) is the causative agent of dengue fever (DF), a mosquito-borne illness endemic to tropical and subtropical regions. There is currently no effective drug or vaccine formulation for the prevention of DF and its more severe forms, i.e., dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). There are two generally available experimental models for the study of DENV pathogenicity as well as the evaluation of potential vaccine candidates. The first model consists of non-human primates, which do not develop symptoms but rather a transient viremia. Second, mouse-adapted virus strains or immunocompromised mouse lineages are utilized, which display some of the pathological features of the infection observed in humans but may not be relevant to the results with regard to the wild-type original virus strains or mouse lineages. In this study, we describe a genetic and pathological study of a DENV2 clinical isolate, named JHA1, which is naturally capable of infecting and killing Balb/c mice and reproduces some of the symptoms observed in DENV-infected subjects. Sequence analyses demonstrated that the JHA1 isolate belongs to the American genotype group and carries genetic markers previously associated with neurovirulence in mouse-adapted virus strains. The JHA1 strain was lethal to immunocompetent mice following intracranial (i.c.) inoculation with a LD(50) of approximately 50 PFU. Mice infected with the JHA1 strain lost weight and exhibited general tissue damage and hematological disturbances, with similarity to those symptoms observed in infected humans. In addition, it was demonstrated that the JHA1 strain shares immunological determinants with the DENV2 NGC reference strain, as evaluated by cross-reactivity of anti-envelope glycoprotein (domain III) antibodies. The present results indicate that the JHA1 isolate may be a useful tool in the study of DENV pathogenicity and will help in the evaluation of anti-DENV vaccine formulations as well as potential therapeutic approaches.Jaime Henrique AmorimRaíza Sales Pereira BizerraRúbens Prince dos Santos AlvesMaria Elisabete Sbrogio-AlmeidaJosé Eduardo LeviMargareth Lara CapurroLuís Carlos de Souza FerreiraPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 9, p e44984 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Jaime Henrique Amorim
Raíza Sales Pereira Bizerra
Rúbens Prince dos Santos Alves
Maria Elisabete Sbrogio-Almeida
José Eduardo Levi
Margareth Lara Capurro
Luís Carlos de Souza Ferreira
A genetic and pathologic study of a DENV2 clinical isolate capable of inducing encephalitis and hematological disturbances in immunocompetent mice.
description Dengue virus (DENV) is the causative agent of dengue fever (DF), a mosquito-borne illness endemic to tropical and subtropical regions. There is currently no effective drug or vaccine formulation for the prevention of DF and its more severe forms, i.e., dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). There are two generally available experimental models for the study of DENV pathogenicity as well as the evaluation of potential vaccine candidates. The first model consists of non-human primates, which do not develop symptoms but rather a transient viremia. Second, mouse-adapted virus strains or immunocompromised mouse lineages are utilized, which display some of the pathological features of the infection observed in humans but may not be relevant to the results with regard to the wild-type original virus strains or mouse lineages. In this study, we describe a genetic and pathological study of a DENV2 clinical isolate, named JHA1, which is naturally capable of infecting and killing Balb/c mice and reproduces some of the symptoms observed in DENV-infected subjects. Sequence analyses demonstrated that the JHA1 isolate belongs to the American genotype group and carries genetic markers previously associated with neurovirulence in mouse-adapted virus strains. The JHA1 strain was lethal to immunocompetent mice following intracranial (i.c.) inoculation with a LD(50) of approximately 50 PFU. Mice infected with the JHA1 strain lost weight and exhibited general tissue damage and hematological disturbances, with similarity to those symptoms observed in infected humans. In addition, it was demonstrated that the JHA1 strain shares immunological determinants with the DENV2 NGC reference strain, as evaluated by cross-reactivity of anti-envelope glycoprotein (domain III) antibodies. The present results indicate that the JHA1 isolate may be a useful tool in the study of DENV pathogenicity and will help in the evaluation of anti-DENV vaccine formulations as well as potential therapeutic approaches.
format article
author Jaime Henrique Amorim
Raíza Sales Pereira Bizerra
Rúbens Prince dos Santos Alves
Maria Elisabete Sbrogio-Almeida
José Eduardo Levi
Margareth Lara Capurro
Luís Carlos de Souza Ferreira
author_facet Jaime Henrique Amorim
Raíza Sales Pereira Bizerra
Rúbens Prince dos Santos Alves
Maria Elisabete Sbrogio-Almeida
José Eduardo Levi
Margareth Lara Capurro
Luís Carlos de Souza Ferreira
author_sort Jaime Henrique Amorim
title A genetic and pathologic study of a DENV2 clinical isolate capable of inducing encephalitis and hematological disturbances in immunocompetent mice.
title_short A genetic and pathologic study of a DENV2 clinical isolate capable of inducing encephalitis and hematological disturbances in immunocompetent mice.
title_full A genetic and pathologic study of a DENV2 clinical isolate capable of inducing encephalitis and hematological disturbances in immunocompetent mice.
title_fullStr A genetic and pathologic study of a DENV2 clinical isolate capable of inducing encephalitis and hematological disturbances in immunocompetent mice.
title_full_unstemmed A genetic and pathologic study of a DENV2 clinical isolate capable of inducing encephalitis and hematological disturbances in immunocompetent mice.
title_sort genetic and pathologic study of a denv2 clinical isolate capable of inducing encephalitis and hematological disturbances in immunocompetent mice.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/b882e572504c4675a87d61f09e5fbdc9
work_keys_str_mv AT jaimehenriqueamorim ageneticandpathologicstudyofadenv2clinicalisolatecapableofinducingencephalitisandhematologicaldisturbancesinimmunocompetentmice
AT raizasalespereirabizerra ageneticandpathologicstudyofadenv2clinicalisolatecapableofinducingencephalitisandhematologicaldisturbancesinimmunocompetentmice
AT rubensprincedossantosalves ageneticandpathologicstudyofadenv2clinicalisolatecapableofinducingencephalitisandhematologicaldisturbancesinimmunocompetentmice
AT mariaelisabetesbrogioalmeida ageneticandpathologicstudyofadenv2clinicalisolatecapableofinducingencephalitisandhematologicaldisturbancesinimmunocompetentmice
AT joseeduardolevi ageneticandpathologicstudyofadenv2clinicalisolatecapableofinducingencephalitisandhematologicaldisturbancesinimmunocompetentmice
AT margarethlaracapurro ageneticandpathologicstudyofadenv2clinicalisolatecapableofinducingencephalitisandhematologicaldisturbancesinimmunocompetentmice
AT luiscarlosdesouzaferreira ageneticandpathologicstudyofadenv2clinicalisolatecapableofinducingencephalitisandhematologicaldisturbancesinimmunocompetentmice
AT jaimehenriqueamorim geneticandpathologicstudyofadenv2clinicalisolatecapableofinducingencephalitisandhematologicaldisturbancesinimmunocompetentmice
AT raizasalespereirabizerra geneticandpathologicstudyofadenv2clinicalisolatecapableofinducingencephalitisandhematologicaldisturbancesinimmunocompetentmice
AT rubensprincedossantosalves geneticandpathologicstudyofadenv2clinicalisolatecapableofinducingencephalitisandhematologicaldisturbancesinimmunocompetentmice
AT mariaelisabetesbrogioalmeida geneticandpathologicstudyofadenv2clinicalisolatecapableofinducingencephalitisandhematologicaldisturbancesinimmunocompetentmice
AT joseeduardolevi geneticandpathologicstudyofadenv2clinicalisolatecapableofinducingencephalitisandhematologicaldisturbancesinimmunocompetentmice
AT margarethlaracapurro geneticandpathologicstudyofadenv2clinicalisolatecapableofinducingencephalitisandhematologicaldisturbancesinimmunocompetentmice
AT luiscarlosdesouzaferreira geneticandpathologicstudyofadenv2clinicalisolatecapableofinducingencephalitisandhematologicaldisturbancesinimmunocompetentmice
_version_ 1718423937593901056